AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6365210 — intervention group
Group type: COMPARATOR
Intervention: Excisional biopsy plus radiation
Number of subjects: 38
Study 30101731 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention engaging adolescents with DOHaD concepts
Number of subjects: 333
Study 30101731 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 333
Study 27511899 — intervention group
Group type: EXPERIMENTAL
Intervention: High miR-155 expression
Number of subjects: 198
Study 27511899 — intervention group
Group type: COMPARATOR
Intervention: Low miR-155 expression
Number of subjects: 198
Study 24523413 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFCA)
Number of subjects: 330
Study 24523413 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AADs)
Number of subjects: 330
Study 24523413 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RFCA and AADs
Number of subjects: 330
Study 24335790 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical benchmarking tool (Essence of Care)
Number of subjects: 6
Study 24335790 — intervention group
Group type: COMPARATOR
Intervention: Detailed information about residents and continence services contact details
Number of subjects: 6
Study 20080918 — intervention group
Group type: EXPERIMENTAL
Intervention: IA injection of 40 mg triamcinolone acetonide
Number of subjects: 79
Study 20080918 — intervention group
Group type: COMPARATOR
Intervention: 1 cc 0.9% saline (placebo)
Number of subjects: 79
Study 19003741 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow cell treatment (injected at 40 sites into the ischemic limb)
Number of subjects: 90
Study 19003741 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham bone marrow punction and 40 saline injections)
Number of subjects: 90
Study 19003741 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow cell treatment
Number of subjects: 90
Study 19003741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 15668596 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 150
Study 15668596 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 150
Study 15668596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 12897302 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte colony-stimulating factor (rhG-CSF) 100 microg/kg
Number of subjects: 0
Study 12897302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10447988 — intervention group
Group type: COMPARATOR
Intervention: Conceptual number mismatch (grammatical number singular, conceptual number plural)
Number of subjects: 0
Study 10447988 — intervention group
Group type: COMPARATOR
Intervention: Sentence/picture matching test
Number of subjects: 0
Study 8526834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold body-cold arm (CB-CA)
Number of subjects: 6
Study 8526834 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm body-cold arm (WB-CA)
Number of subjects: 6
Study 8526834 — intervention group
Group type: COMPARATOR
Intervention: Cold body-warm arm (CB-WA)
Number of subjects: 6
Study 1971767 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow withdrawal (SW)
Number of subjects: 31
Study 1971767 — intervention group
Group type: COMPARATOR
Intervention: Abrupt withdrawal under propranolol cover (PW)
Number of subjects: 31
Study 1971767 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SW and PW)
Number of subjects: 31
Study 1971767 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger subjects and those more severely anxious at the start
Number of subjects: 31
Study 85052 — intervention group
Group type: EXPERIMENTAL
Intervention: P.U.V.A. (8‐methoxypsoralen and long‐wave ultraviolet light)
Number of subjects: 224
Study 85052 — intervention group
Group type: COMPARATOR
Intervention: Dithranol
Number of subjects: 224
Study 85052 — intervention group
Group type: EXPERIMENTAL
Intervention: P.U.V.A.
Number of subjects: 224
Study 85052 — intervention group
Group type: EXPERIMENTAL
Intervention: P.U.V.A. for patients who failed dithranol or needed methotrexate
Number of subjects: 224
Study 85052 — intervention group
Group type: COMPARATOR
Intervention: Dithranol for patients who failed P.U.V.A.
Number of subjects: 224
Study 30924301 — intervention group
Group type: COMPARATOR
Intervention: Subcision and needling
Number of subjects: 30
Study 30924301 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcision, needling, and topical application of PRP
Number of subjects: 30
Study 28318619 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity motivational intervention group with previously trained nurse (G1)
Number of subjects: 176
Study 28318619 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower intensity consultation, non-motivational group, with digital platform support (G2)
Number of subjects: 176
Study 28318619 — intervention group
Group type: COMPARATOR
Intervention: Recommendation to lose weight and usual follow-up (G3)
Number of subjects: 176
Study 28318619 — intervention group
Group type: COMPARATOR
Intervention: G1 vs G3 for TG
Number of subjects: 176
Study 28318619 — intervention group
Group type: COMPARATOR
Intervention: G1 vs G2 for HDL-C
Number of subjects: 176
Study 25819042 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine pranobex (1 g four times daily)
Number of subjects: 288
Study 25819042 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir (200 mg five times daily)
Number of subjects: 288
Study 24321275 — intervention group
Group type: EXPERIMENTAL
Intervention: C7-T8 relative phase at 0.67 and 0.89 m/s
Number of subjects: 38
Study 24321275 — intervention group
Group type: EXPERIMENTAL
Intervention: C7-sacrum and T8-sacrum relative phases
Number of subjects: 38
Study 24321275 — intervention group
Group type: EXPERIMENTAL
Intervention: C7-T8 and T8-sacrum relative phases
Number of subjects: 38
Study 24321275 — intervention group
Group type: EXPERIMENTAL
Intervention: T8-sacrum relative phase
Number of subjects: 38
Study 21594560 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (100 mg)
Number of subjects: 60
Study 21594560 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid (400 mg)
Number of subjects: 60
Study 21594560 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of D-cycloserine and Valproic acid
Number of subjects: 60
Study 21594560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19273715 — intervention group
Group type: EXPERIMENTAL
Intervention: Point of Information and Support (PIS)
Number of subjects: 3286
Study 19273715 — intervention group
Group type: COMPARATOR
Intervention: No PIS (Control)
Number of subjects: 3286
Study 17211242 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg/day
Number of subjects: 46
Study 17211242 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg/day
Number of subjects: 46
Study 15564035 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation during sleep
Number of subjects: 12
Study 15564035 — intervention group
Group type: COMPARATOR
Intervention: Reference group (no non-invasive ventilation)
Number of subjects: 12
Study 11535952 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor (375 mg BID for 10 days)
Number of subjects: 200
Study 11535952 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (625 mg BID for 10 days)
Number of subjects: 200
Study 9692813 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg/kg G‐CSF
Number of subjects: 24
Study 9692813 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 microg/kg G‐CSF
Number of subjects: 24
Study 9692813 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF treatment
Number of subjects: 24
Study 9692813 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF mobilization
Number of subjects: 24
Study 9692813 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 or more cycles of melphalan pretreatment
Number of subjects: 24
Study 9692813 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy
Number of subjects: 24
Study 8778145 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (AA) 1000 mg daily for 4 weeks
Number of subjects: 10
Study 1969197 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA 5% cream
Number of subjects: 80
Study 1969197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 7276678 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: MFC (mitomycin C, 5 fluorouracil, cytosine arabinoside) intravenously for 5 weeks, followed by oral 5 FU dry syrup for 2 years
Number of subjects: 244
Study 7276678 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: FT 207 substituted for 5 FU, same schedule as Group A
Number of subjects: 244
Study 7276678 — intervention group
Group type: COMPARATOR
Intervention: Group C: no chemotherapy added to surgery
Number of subjects: 244
Study 31563527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 2311
Study 31563527 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 2311
Study 29752225 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Childbirth and Parenting programme
Number of subjects: 104
Study 29752225 — intervention group
Group type: COMPARATOR
Intervention: Traditional education classes
Number of subjects: 104
Study 27888052 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs (used in 2368 patients, 40.2%)
Number of subjects: 5887
Study 27888052 — intervention group
Group type: COMPARATOR
Intervention: No NSAIDs (not using NSAIDs)
Number of subjects: 5887
Study 25685056 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestion
Number of subjects: 270
Study 25685056 — intervention group
Group type: EXPERIMENTAL
Intervention: Dreamfilm
Number of subjects: 270
Study 25685056 — intervention group
Group type: COMPARATOR
Intervention: Control (etomidate & sevoflurane)
Number of subjects: 270
Study 25685056 — intervention group
Group type: COMPARATOR
Intervention: Control (propofol & sevoflurane)
Number of subjects: 270
Study 25685056 — intervention group
Group type: COMPARATOR
Intervention: Control (propofol & propofol)
Number of subjects: 270
Study 24164569 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + probiotic (Lactobacillus reuteri lozenges, used two times a day for 12 weeks)
Number of subjects: 30
Study 24164569 — intervention group
Group type: COMPARATOR
Intervention: SRP + placebo
Number of subjects: 30
Study 20146674 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg/day (n=19)
Number of subjects: 53
Study 20146674 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day (n=19)
Number of subjects: 53
Study 20146674 — intervention group
Group type: COMPARATOR
Intervention: No statin (control group, n=15)
Number of subjects: 53
Study 18985817 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk containing Bifidobacterium lactis DN-173010
Number of subjects: 135
Study 16889324 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual art therapy for 1 hour/week during postoperative radiotherapy
Number of subjects: 41
Study 16889324 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 41
Study 12911442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal smoking cessation intervention (individual counseling + optional nicotine replacement therapy)
Number of subjects: 647
Study 12911442 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard counseling from a midwife)
Number of subjects: 647
Study 11004357 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (500-microg tablet vaginally, every 6 hours for maximum of two doses)
Number of subjects: 110
Study 11004357 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin E2 (3-mg tablet vaginally, every 6 hours for maximum of two doses)
Number of subjects: 110
Study 11004357 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate
Number of subjects: 110
Study 11004357 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate and Prostaglandin E2
Number of subjects: 110
Study 8951258 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 48
Study 8951258 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer simulated driving test (ADHD group)
Number of subjects: 48
Study 8951258 — intervention group
Group type: COMPARATOR
Intervention: Control group (without ADHD)
Number of subjects: 48
Study 1903167 — intervention group
Group type: COMPARATOR
Intervention: Urokinase (UK) 96 x 10(4)IU
Number of subjects: 198
Study 1903167 — intervention group
Group type: EXPERIMENTAL
Intervention: rt-PA2 (2000 x 10(4)IU, 33 mg)
Number of subjects: 198
Study 1903167 — intervention group
Group type: EXPERIMENTAL
Intervention: rt-PA3 (3000 x 10(4)IU, 50 mg)
Number of subjects: 198
Study 6938996 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol plus lithium
Number of subjects: 36
Study 6938996 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol plus placebo
Number of subjects: 36
Study 31685315 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermophilic anaerobic digestion (55 ℃)
Number of subjects: 0
Study 31685315 — intervention group
Group type: COMPARATOR
Intervention: Mesophilic anaerobic digestion (35 ℃)
Number of subjects: 0
Study 31685315 — intervention group
Group type: EXPERIMENTAL
Intervention: Both temperatures
Number of subjects: 0
Study 31685315 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermophilic and mesophilic AD
Number of subjects: 0
Study 31519221 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed ultrasound treatment
Number of subjects: 14
Study 31519221 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 14
Study 28257741 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery-first approach
Number of subjects: 50
Study 28257741 — intervention group
Group type: COMPARATOR
Intervention: Orthodontics-first approach
Number of subjects: 50
Study 26352164 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel community health worker‐based multilevel discharge intervention
Number of subjects: 300
Study 26352164 — intervention group
Group type: COMPARATOR
Intervention: Standard discharge care (usual care)
Number of subjects: 300
Study 23399456 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface peroneal nerve stimulator (PNS)
Number of subjects: 110
Study 23399456 — intervention group
Group type: COMPARATOR
Intervention: Usual care (ankle-foot orthosis or no device)
Number of subjects: 110
Study 22025372 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (CTD)
Number of subjects: 8012
Study 22025372 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 8012
Study 19882056 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg oral palm vitamin E
Number of subjects: 79
Study 19882056 — intervention group
Group type: COMPARATOR
Intervention: 1.5 g oral glucosamine sulphate
Number of subjects: 79
Study 17492948 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of 17beta‐oestradiol orally combined with 100 mg progesterone
Number of subjects: 196
Study 17492948 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 microg of 17beta‐oestradiol transdermally combined with 100 mg progesterone
Number of subjects: 196
Study 17492948 — intervention group
Group type: COMPARATOR
Intervention: Triple dummy placebo
Number of subjects: 196
Study 15190690 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible-head toothbrush 1
Number of subjects: 20
Study 15190690 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible-head toothbrush 2
Number of subjects: 20
Study 15190690 — intervention group
Group type: COMPARATOR
Intervention: Non-flexible-head toothbrush (control)
Number of subjects: 20
Study 11499745 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dietary sodium restriction (sodium intake <100 mmol/day)
Number of subjects: 35
Study 11499745 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise (daily walking)
Number of subjects: 35
Study 9923414 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (target concentration range 10-30 ng/mL during the first 8 weeks, tapering 20% per month during months 3-6)
Number of subjects: 0
Study 9923414 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (target concentration range 150-450 ng/mL during the first 8 weeks, tapering 20% per month during months 3-6)
Number of subjects: 0
Study 9923414 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus and Cyclosporine (both treatments)
Number of subjects: 0
Study 8117018 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction drainage
Number of subjects: 107
Study 8117018 — intervention group
Group type: COMPARATOR
Intervention: No drain (control)
Number of subjects: 107
Study 3405718 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills program (experimental group)
Number of subjects: 16
Study 3405718 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 16
Study 3405718 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 16
Study 29504468 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face delivery of the PILI@Work Program
Number of subjects: 217
Study 29504468 — intervention group
Group type: COMPARATOR
Intervention: DVD delivery of the PILI@Work Program
Number of subjects: 217
Study 29504468 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (face-to-face and DVD)
Number of subjects: 217
Study 29504468 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance in Phase 1 of the intervention
Number of subjects: 217
Study 29504468 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline systolic blood pressure
Number of subjects: 217
Study 27147120 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU oral vitamin D weekly for eight weeks
Number of subjects: 60
Study 27147120 — intervention group
Group type: COMPARATOR
Intervention: Placebo weekly for eight weeks
Number of subjects: 60
Study 25709408 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoretic application of 1% diclofenac (DF) for 20 minutes
Number of subjects: 60
Study 25709408 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusive application of 1% diclofenac (DF) for 20 minutes
Number of subjects: 60
Study 25709408 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive application of 1% diclofenac (DF) for 20 minutes
Number of subjects: 60
Study 25709408 — intervention group
Group type: COMPARATOR
Intervention: Control (no application)
Number of subjects: 60
Study 23510162 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual feedback and multimodal games
Number of subjects: 48
Study 21395878 — intervention group
Group type: EXPERIMENTAL
Intervention: ST11-fermented milk
Number of subjects: 31
Study 19093003 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotating walker
Number of subjects: 4
Study 19093003 — intervention group
Group type: COMPARATOR
Intervention: Standard point-light walkers (non-rotating)
Number of subjects: 4
Study 19093003 — intervention group
Group type: COMPARATOR
Intervention: Rotating cuboid (non-biological object)
Number of subjects: 4
Study 16574032 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 994
Study 16574032 — intervention group
Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 994
Study 14570299 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear transformation (u = 0.44v + 0.49)
Number of subjects: 299
Study 14570299 — intervention group
Group type: EXPERIMENTAL
Intervention: Curvilinear transformation (u = 1 - [1 - v]1.6)
Number of subjects: 299
Study 14570299 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative linear model (u = v + 0.018)
Number of subjects: 299
Study 14570299 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative published curvilinear model (u = 1 - [1 - v]2.3)
Number of subjects: 299
Study 10876454 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalad group (needle orifice direction)
Number of subjects: 0
Study 10876454 — intervention group
Group type: COMPARATOR
Intervention: Caudad group (needle orifice direction)
Number of subjects: 0
Study 10876454 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalad group
Number of subjects: 0
Study 10876454 — intervention group
Group type: COMPARATOR
Intervention: Caudad group
Number of subjects: 0
Study 9206757 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatosensory evoked potentials (SEP) recorded before and after cervical spine surgery
Number of subjects: 11
Study 9206757 — intervention group
Group type: EXPERIMENTAL
Intervention: P14 and P30 potentials
Number of subjects: 11
Study 9206757 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP recording
Number of subjects: 11
Study 8471899 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day norfloxacin treatment
Number of subjects: 0
Study 8471899 — intervention group
Group type: COMPARATOR
Intervention: 7-day norfloxacin treatment
Number of subjects: 0
Study 2951925 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol
Number of subjects: 30
Study 2951925 — intervention group
Group type: COMPARATOR
Intervention: Acebutolol
Number of subjects: 30
Study 31368271 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Sifeng (EX-UE10) combined with Wang's Baochi Pills
Number of subjects: 201
Study 31368271 — intervention group
Group type: COMPARATOR
Intervention: Wang's Baochi Pills only (Control)
Number of subjects: 201
Study 29909301 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic CBT
Number of subjects: 19
Study 27551820 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-controlled group (chose difficulty progression)
Number of subjects: 60
Study 27551820 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-controlled group
Number of subjects: 60
Study 27551820 — intervention group
Group type: COMPARATOR
Intervention: Yoked group (no choice in difficulty progression)
Number of subjects: 60
Study 24812628 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity swim training (HIT)
Number of subjects: 62
Study 24812628 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity swim training (MOD)
Number of subjects: 62
Study 24812628 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 62
Study 22217551 — intervention group
Group type: EXPERIMENTAL
Intervention: Autofluorescence visualization device (VELscope) in addition to white light examination
Number of subjects: 289